[Form 4] Compass, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Compass, Inc. reporting person Scott R. Wahlers (CFO & CAO) received a grant of 316,724 Restricted Stock Units (RSUs) on 08/25/2025. Each RSU converts to one share of Class A Common Stock upon settlement. The filing shows 316,724 shares beneficially owned following the grant and indicates the award price is $0. The RSUs vest 8.33% on December 15, 2025, then 6.25% quarterly through June 15, 2029, with a final 4.17% on August 15, 2029, each subject to continued service on the vesting dates. The form is signed by an attorney-in-fact on 08/26/2025.
Positive
- Long-term alignment: RSUs vest over multiple years, aligning the CFO/CAO with shareholder interests
- Retention focus: Regular quarterly vesting supports executive retention through 2029
Negative
- Potential dilution: 316,724 RSUs convert to shares upon settlement which could dilute existing shareholders (outstanding share count not provided)
- Concentration of compensation: Large single grant increases executive equity stake without disclosed performance conditions
Insights
TL;DR: Large RSU grant to CFO/CAO aligns executive pay with shareholder value but concentrates compensation risk over multi-year vesting.
The 316,724 RSU award is a substantial equity grant that vests over nearly four years, which ties executive compensation to long-term share performance and retention. The zero purchase price indicates this is a service-based compensation award rather than a purchase. The staged vesting schedule with an initial smaller tranche and regular quarterly vesting thereafter suggests a design focused on retention and ongoing performance alignment. Materiality depends on Compass’s outstanding share count, which is not provided here; without that context, we cannot quantify dilution or percent ownership.
TL;DR: The grant structure is typical of senior executive compensation, emphasizing multi-year retention and alignment with shareholders.
The award vests 8.33% then 6.25% quarterly and 4.17% at final date, a schedule that provides steady incremental vesting through 2029. The reporting shows direct beneficial ownership of 316,724 shares post-grant and an exercise/price of $0, indicating full-value RSUs rather than options. For investors, key missing data are total outstanding shares and any performance conditions; absent those, the grant should be viewed as a standard retention vehicle rather than an immediately dilutive cash transaction.